Scientists have characterized the role of thousands of mutations in the BRCA2 cancer gene, findings that may help reassure ...

Susan M. Domchek, MD, FASCOPHILADELPHIA - Susan M. Domchek, MD, FASCO, has been recognized by the American Society of Clinical Oncology (ASCO) with ...

Testing for BRCA mutations linked to breast and ovarian cancers could become easier and more accessible with the help of artificial intelligence, potentially allowing earlier treatment.

The genetic testing results also inform patients’ family members about their cancer risks so they can be proactive in screening and prevention. For now, GENETECA™ is only available to people with ...

Katrina Cooke and Ashley Dostefano share their personal journeys, reflecting on the challenges they faced, the victories they ...

Research continues in this field of precision oncology and there has been an explosion of novel drugs in this field ...

2. Ovarian Cancer: Research indicates that a woman's chance of developing ovarian cancer may be influenced by hormonal ...

A study of men with a family history of prostate cancer has discovered an inherited form of prostate cancer. The inherited ...

Genialis and Debiopharm expand collaboration to develop RNA-based predictive biomarkers for DDR therapies, advancing precision oncology.

The next day, Rudman realized the way to pay it forward was to give the gift of support, resources and community to anyone in Kansas City who is impacted by breast cancer. “People always say, ‘Welcome ...

Given the latest data, which includes troubling trends in pancreatic cancer and growing inequities in cancer outcomes for ...

Sarah Anderson, oncology strategy lead director, Novotech, discusses the growing prominence of triple-negative breast cancer ...